ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.
ASTA Letter to Senator Durbin in Support of Proposed Food Safety Legislation
ASTA sent a letter to Senator Durbin in March 2009 supporting legislation to reform the food safety system, providing comments on specific provisions included in the bill and offering to work with the Senator's staff on modifications that would facilitate implementation and assure the objectives are met.
